127 related articles for article (PubMed ID: 15315851)
1. A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy.
Talwar GP; Raina K; Gupta JC; Ray R; Wadhwa S; Ali MM
Vaccine; 2004 Sep; 22(27-28):3713-21. PubMed ID: 15315851
[TBL] [Abstract][Full Text] [Related]
2. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy.
Finstad CL; Wang CY; Kowalski J; Zhang M; Li ML; Li XM; Xia WG; Bosland MC; Murthy KK; Walfield AM; Koff WC; Zamb TJ
Vaccine; 2004 Mar; 22(9-10):1300-13. PubMed ID: 15003660
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate.
Junco JA; Peschke P; Zuna I; Ehemann V; Fuentes F; Bover E; Pimentel E; Basulto R; Reyes O; Calzada L; Castro MD; Arteaga N; López Y; Garay H; Hernández H; Bringas R; Guillén GE
Vaccine; 2007 Dec; 25(50):8460-8. PubMed ID: 18022737
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone/human chorionic gonadotropin beta based recombinant antibodies and vaccines.
Talwar GP; Vyas HK; Purswani S; Gupta JC
J Reprod Immunol; 2009 Dec; 83(1-2):158-63. PubMed ID: 19854518
[TBL] [Abstract][Full Text] [Related]
5. Gonadotrophin releasing hormone-based vaccine, an effective candidate for prostate cancer and other hormone-sensitive neoplasms.
Junco JA; Basalto R; Fuentes F; Bover E; Reyes O; Pimentel E; Calzada L; Castro MD; Arteaga N; López Y; Hernández H; Bringas R; Garay H; Peschke P; Bertot J; Guillén G
Adv Exp Med Biol; 2008; 617():581-7. PubMed ID: 18497085
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal microSPECt/CT imaging and pharmacokinetics of synthetic luteinizing hormone-releasing hormone (LHRH) vaccine in rats.
Chang CH; Hsu WC; Wang CY; Jan ML; Tsai TH; Lee TW; Lynn SG; Yeh CH; Chang TJ
Anticancer Res; 2007; 27(5A):3251-8. PubMed ID: 17970068
[TBL] [Abstract][Full Text] [Related]
7. Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer.
Simms MS; Scholfield DP; Jacobs E; Michaeli D; Broome P; Humphreys JE; Bishop MC
Br J Cancer; 2000 Aug; 83(4):443-6. PubMed ID: 10945488
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model.
Xu J; Zhu Z; Wu J; Liu W; Shen X; Zhang Y; Hu Z; Zhu D; Roque RS; Liu J
Cancer Lett; 2008 Feb; 259(2):240-50. PubMed ID: 18039558
[TBL] [Abstract][Full Text] [Related]
9. Vaccines for control of fertility.
Talwar GP; Singh O; Pal R; Chatterjee N; Suri AK; Shaha C
Indian J Exp Biol; 1992 Nov; 30(11):947-50. PubMed ID: 1293038
[TBL] [Abstract][Full Text] [Related]
10. A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant.
Jinshu X; Jingjing L; Duan P; Zheng Z; Ding M; Jie W; Rongyue C; Zhuoyi H; Roque RS
Vaccine; 2005 Sep; 23(40):4834-43. PubMed ID: 15996796
[TBL] [Abstract][Full Text] [Related]
11. Carrier-induced suppression of the antibody response to a 'self' hapten.
Sad S; Gupta HM; Talwar GP; Raghupathy R
Immunology; 1991 Oct; 74(2):223-7. PubMed ID: 1748470
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an anti-fertility vaccine based on mammalian gonadotrophin releasing hormone (GnRH-I)--a histological comparison in male animals.
Ferro VA; Khan MA; McAdam D; Colston A; Aughey E; Mullen AB; Waterston MM; Harvey MJ
Vet Immunol Immunopathol; 2004 Sep; 101(1-2):73-86. PubMed ID: 15261694
[TBL] [Abstract][Full Text] [Related]
13. Effect of immunisation against gonadotrophin releasing hormone isoforms (mammalian GnRH-I, chicken GnRH-II and lamprey GnRH-III) on murine spermatogenesis.
Khan MA; Prevost M; Waterston MM; Harvey MJ; Ferro VA
Vaccine; 2007 Mar; 25(11):2051-63. PubMed ID: 17240004
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
Johnson LE; Frye TP; Arnot AR; Marquette C; Couture LA; Gendron-Fitzpatrick A; McNeel DG
Vaccine; 2006 Jan; 24(3):293-303. PubMed ID: 16115700
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy.
Ferro VA; Costa R; Carter KC; Harvey MJ; Waterston MM; Mullen AB; Matschke C; Mann JF; Colston A; Stimson WH
Vaccine; 2004 Feb; 22(8):1024-31. PubMed ID: 15161080
[TBL] [Abstract][Full Text] [Related]
16. Immunization against luteinizing hormone-releasing hormone fusion proteins does not decrease prostate cancer in the transgenic adenocarcinoma mouse prostate model.
Hill RE; de Avila DM; Bertrand KP; Greenberg NM; Reeves JJ
Exp Biol Med (Maywood); 2003 Jul; 228(7):818-22. PubMed ID: 12876301
[TBL] [Abstract][Full Text] [Related]
17. Identification of dominant epitopes of synthetic immunocontraceptive vaccines that induce antibodies in dogs.
Yu M; Zeng W; Pagnon J; Walker J; Ghosh S; Wang LF; Jackson DC
Vaccine; 2005 Aug; 23(37):4589-97. PubMed ID: 15927323
[TBL] [Abstract][Full Text] [Related]
18. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds.
Walker J; Ghosh S; Pagnon J; Colantoni C; Newbold A; Zeng W; Jackson DC
Vaccine; 2007 Oct; 25(41):7111-9. PubMed ID: 17825958
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in contraceptive vaccine development: a mini-review.
Naz RK; Gupta SK; Gupta JC; Vyas HK; Talwar AG
Hum Reprod; 2005 Dec; 20(12):3271-83. PubMed ID: 16113040
[TBL] [Abstract][Full Text] [Related]
20. The effects of recombinant LHRH fusion proteins on testicular development and histology in ram lambs.
Ulker H; Kanter M; Gökdal O; De Avila DM; Reeves JJ
Dtsch Tierarztl Wochenschr; 2001 Nov; 108(11):459, 462-4. PubMed ID: 11765601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]